Compare BRBS & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRBS | CYRX |
|---|---|---|
| Founded | 1893 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.3M | 472.7M |
| IPO Year | N/A | N/A |
| Metric | BRBS | CYRX |
|---|---|---|
| Price | $4.30 | $9.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.83 |
| AVG Volume (30 Days) | 148.3K | ★ 345.1K |
| Earning Date | 01-29-2026 | 03-03-2026 |
| Dividend Yield | ★ 5.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.11 | ★ 1.27 |
| Revenue | $95,697,000.00 | ★ $243,795,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | $38.64 | ★ $7.51 |
| Revenue Growth | N/A | ★ 41.27 |
| 52 Week Low | $2.92 | $4.58 |
| 52 Week High | $4.79 | $11.45 |
| Indicator | BRBS | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.26 | 39.32 |
| Support Level | $4.25 | $10.39 |
| Resistance Level | $4.37 | $10.39 |
| Average True Range (ATR) | 0.10 | 0.50 |
| MACD | -0.00 | -0.19 |
| Stochastic Oscillator | 4.35 | 9.82 |
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.